https://www.selleckchem.com/pr....oducts/5-n-ethyl-n-i
A median OS of 11months (range 0-61months) for the total study population and 16months (range 2-61months) for the patients with three or more PIPACs was observed. For 10 patients (7%) who underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, the median OS was 15months (minimum, 4months; maximum, 27months). Multivariate analysis showed three or more PIPACs to be an independent prognostic factor for improved OS (hazard ratio, 0.36; p 0.0001). Repetitive PIPAC-C/D ± systemic chemot
Like
Comment
Share
